Status:
COMPLETED
Different Bupivacaine Volumes in Infiltration Between Popliteal Artery and Capsule of Knee Block
Lead Sponsor:
Cairo University
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
comparing between three different volumes; 15, 20 \& 25 ml of 0.25% bupivacaine to determine the best volume of Infiltration Between Popliteal Artery and Capsule of Knee (IPACK) block following adduct...
Detailed Description
105 participants will be randomized into three groups based on computer generated numbers using online randomization program Preoperative assessment is conducted on the patients that will be enrolled...
Eligibility Criteria
Inclusion
- patients undergoing knee arthroscopy surgery.
- Age between 18 years and 65 years.
- Both sexes
- ASA I \& ASA II
Exclusion
- Patients' refusal
- Allergy to any drug that will be used in the study
- Psychological or mental disorders.
- Disturbance of Conscious level.
- Uncooperative patients
- Coagulopathy
- Contraindications to spinal anaesthesia (e.g.: severe mitral stenosis)
Key Trial Info
Start Date :
December 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2024
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT05438992
Start Date
December 15 2023
End Date
April 20 2024
Last Update
April 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alainy hospitals
Cairo, Egypt, 11562